|
BX54602 |
4-[(2-methyl-2,3-dihydroindol-1-yl)sulfonyl]-2,1,3-benzoxadiazole |
443103-67-1 |
C15H13N3O3S |
315.3470 |
VIEW DETAILS > |
|
BU56512 |
4-morpholin-4-ylsulfonyl-2,1,3-benzoxadiazole |
443103-96-6 |
C10H11N3O4S |
269.2770 |
VIEW DETAILS > |
|
AX64588 |
A2A receptor antagonist 1 |
443103-97-7 |
C16H12FN5O |
309.2978 |
VIEW DETAILS > |
|
AG20779 |
TP 235 |
443104-02-7 |
C34H43N3O3 |
541.7235 |
VIEW DETAILS > |
|
BV72465 |
N-propan-2-yl-2,1,3-benzoxadiazole-4-sulfonamide |
443104-03-8 |
C9H11N3O3S |
241.2669 |
VIEW DETAILS > |
|
BS14249 |
N-(2,5-difluorophenyl)-2,1,3-benzothiadiazole-4-sulfonamide |
443104-98-1 |
C12H7F2N3O2S2 |
327.3297 |
VIEW DETAILS > |
|
BV66121 |
4-[4-(2-chlorophenyl)piperazin-1-yl]sulfonyl-2,1,3-benzothiadiazole |
443105-03-1 |
C16H15ClN4O2S2 |
394.8989 |
VIEW DETAILS > |
|
AG17473 |
4-([4-(2-Methoxyphenyl)-6-(trifluoromethyl)pyrimidin-2-yl]sulfonyl)butanoic acid |
443105-09-7 |
C16H15F3N2O5S |
404.3609 |
VIEW DETAILS > |
|
BU29522 |
N-[3-acetyl-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-2H-1,3,4-thiadiazol-5-yl]acetamide |
443105-23-5 |
C14H13F4N3O3S |
379.3299 |
VIEW DETAILS > |
|
BY87689 |
N-[4-acetyl-5-methyl-5-(4-phenylphenyl)-1,3,4-thiadiazol-2-yl]acetamide |
443105-34-8 |
C19H19N3O2S |
353.4381 |
VIEW DETAILS > |